Skip to main content
. 2021 Nov 18;29(4):4880–4892. doi: 10.1007/s11356-021-17486-3

Table 3.

Summary of studies on plasma combination technologies for virus inactivation

Combination systems Virus types Experimental conditions Results Ref
Non-thermal plasma-activated by NaCl or H2O2 solutions Newcastle disease virus (NDV) 10 mL sterile distilled water, 0.9% NaCl, and 0.3% H2O2 solutions Complete inactivation of NDV after only 30 min of treatment (Su et al. 2018)
Atmospheric pressure non-thermal plasma (NTP) jet with Ar/O2/N2 Newcastle disease virus (NDV) strain and H9N2 avian influenza virus (AIV) A mixture containing 88% Ar, 2% O2, and 10% N2 at a flow rate of 5 L/min was used as working gas Complete inactivation in 2 min of treatment for both NDV and AIV (Wang et al. 2016)
Cold oxygen plasma + an internal classic UV-C lamp Respiratory syncytial virus (RSV) and human parainfluenza virus type 3 (hPIV-3), and influenza virus A (H5N2) 50 mL of viral pellets were suspended in PBS More than 99.98 of reduction regardless of the virus type (Assadi et al. 2015)
Non-thermal plasma coupled to a packed-bed dielectric barrier discharge reactor Aerosols of phage MS2 At 30 kV and an airflow rate of 170 standard liters per minute A reduction of ~ 2 log of the MS2 inactivated and ~ 0.35 log physically removed in the packed bed was observed (Xia et al. 2020)
Packed-bed dielectric barrier discharge non-thermal plasma combined with filtration Porcine reproductive and respiratory syndrome virus (PRRSv From 12 to 30 kV with RH = 38–49% at 5–12 cfm More than 40% at 12 cfm and more than 80% at 5 cfm of reduction regardless of the virus SARS (MS2) (Xia et al. 2019)